The project is a collaboration between Dr. Antoni Artigas, from the Parc Taulí Foundation, Dr. Anna Roig, of the institute of Materials Science of Barcelona (ICMAB-CSIC), and Dr. Daniel Closa, from the Institute of Biomedical Research of Barcelona (IIBB-CSIC).

The study aims to create a therapeutic product formed by the basic components of mesenchymal stem cells which will improve the injury effects produced in sepsis. The researchers will identify and analyze the active components of these cells and subsequently encapsulate them in the form of nanoparticles in order to provide a new therapeutic strategy to regenerate tissues injured by sepsis.

The translation to the clinic of this product would allow to solve the  immediate administration in the patients with sepsis. The study will last for three years and has also been presented to other European research calls.